Back to results
US 2014/0005412 A1Published application
TREATMENT OF ARTERIAL AGEING BY HMG CoA REDUCTASE INHIBITOR
AssigneeFarmicom Pharmaceutical Company D.O.O.
InventorMiso Sabovic
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical combination composition comprising at least one HMG-CoA reductase inhibitor in a subtherapeutic dose and which is designed to prevent and/or to reduce the ageing of the body, particularly for use in prevention, reduction or reversal of arterial ageing in apparently healthy subjects.
Claims2
A pharmaceutical composition comprising
- at least one HMG-CoA reductase inhibitor in a subtherapeutic daily dose, for use in the prevention, reduction or reversal of arterial ageing in apparently healthy subjects.
2-76. (canceled)
Dependencies are inferred from the claim text.